Pharmacoeconomics outcomes research

Clinical case reports of unusual treatments or response to therapy have presented a plethora of questions that remain to be answered. Case series and descriptions of experience with treatment protocols or the impact of pharmacist interventions are useful contributions to the literature. Evaluation of economics and outcomes has been an important area of research in critical care. The critically ill patient patient typically receives a large number of different and often expensive medications, and is monitored with expensive devices. Pharmacists have characterized various aspects of the cost of care, although comprehensive pharmacoeconomic outcome research is... 

Other institutional programs that typically involve pharmacists include pharmacoeconomics, outcomes research and management, quality improvement, and reimbursement assistance programs. 

Bakst A, Meletiche D, Arnold R, et al. The Avandia Worldwide Awareness Registry (AWARe ) an Internet-based program for evaluation of clinical, humanistic and economic outcomes of patients with type 2 diabetes. International Society for Pharmacoeconomics and Outcomes Research Sixth Annual International Meeting. Philadelphia, Pennsylvania, 2001. 

Lewis NJ, Patwell IT, Briesacher BA. The role of insurance claims databases in drug therapy outcomes research. Pharmacoeconomics 1993 4 323-30. 

Dr. Harrison is Assistant Professor of Pharmacy Administration at the University of Oklahoma Health Sciences Center College of Pharmacy. He received a B.S. in pharmacy from the University of Missouri—Kansas City. He received an M.S. in pharmacy and a Ph.D. in pharmaceutical sciences from the University of Arizona. Dr. Harrison has experience in many areas of pharmacy operations—retail, institutional, and research. Dr. Harrison teaches courses in research design, biostatistics, and pharmacoeconomics. Dr. Harrisons research interests are in the economic analyses of pharmaceutical services, outcomes research, and strategic planning by pharmacy institutions and businesses. 

International Society for Pharmacoeconomic and Outcomes Research (ISPOR)... 

Other, more complex terms are defined and described in standard textbooks of epidemiology and statistics (q.v.) and included in two excellent lexicons, the Dictionary of Epidemiology (Last, 2001) and, more recently, a very useful Lexicon from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 

ISPOR—International Society for Pharmacoeconomics and Outcomes Research, Lawrenceville, New Jersey, U.S.A. 

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, 501(c)(3) member organization governed by an annually elected board of directors, with administrative headquarters located in the heart of central New Jersey s pharmaceutical corridor. (3100 Princeton Pike, Building 3, Suite D, Lawrenceville, New Jersey 08648 Tel 609-219-0773 Fax 609-219-0774. Its mission is to translate research and outcomes/results in pharmacoeconomics into practice to ensure fair and efficient distribution of healthcare resources. 

With a steadily growing membership of 2000 representing 29 countries, ISPOR remains steadfast in its mission to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce healthcare resources wisely, fairly, and efficiently. The Society serves the public interest by ... 

Pharmacoeconomics and Outcomes Research Curriculum Development, North America. 

Currently, ISPOR initiatives include developing standards of research practices to guide the activities of those conducting pharmacoeconomics and outcomes research, and developing educational programs to communicate those research results to healthcare decision makers who could greatly benefit from it. 

LEXICON—a unique dictionary of pharmacoeconomics and outcomes research terminology. 

The Annual International Meeting (generally held in May each year) and Annual European Conference (generally held in November or December each year)— promote the discipline of pharmacoeconomics and outcomes research through networking and education. 

Managed care systems offer innovative pharmacy practice positions in such areas as pharmacoeconomics, disease state management, outcomes research, wellness program management, and technology assessment. For individuals willing to expand their pharmacy practice and develop new skills, these positions can offer unique opportunities and growth. 

International Society for Pharmacoeconomics and Outcomes Research, ISPOR Lexicon Pashos, Klein, Wanke, L.A., Eds. ISPOR New Jersey, 1998. Spilker, B. In Quality of Life and Pharmacoeconomics in Clinical Trials 2nd Ed. Spilker, B., Eds. Lippincott-Raven Philadelphia, PA, 1996. 

Bootman JL. Pharmacoeconomics and outcomes research. Am J Health System Pharm 1995 52(suppl 3) S16-S19. 

In recent years pharmacoeconomics has been used as a term to describe the identification, measurement and comparison of the costs and consequences of pharmaceutical products and services (Bootman et al 1996). As such, pharmacoeconomics focuses primarily on pharmaceuticals, and attempts to evaluate the economic and humanistic impact of drug therapy. Pharmacoeconomic tools are derived from a variety of sources, including the fields of economics and outcomes research. Quite often the pharmacoeconomist will bring to the development team skills and experience in quality of life, patient satisfaction and other patient-centered measures. Health economists and a pharmacoeco-nomists differ (while the terms are sometimes used interchangeably), in having stronger backgrounds in the theoretical and applied aspects of health economics, respectively. A researcher with solid... 

---